Home / Dr. Soliman Abdel Kader Fakeeh Hospital Co. / 2025 Annual Results

Dr. Soliman Abdel Kader Fakeeh Hospital Co. 2025 Annual Results

Revenue

SAR 3.09B

Net Profit

SAR 248M

EPS

SAR 1.26

Operating Cash Flow

SAR 454M

Dr. Soliman Abdel Kader Fakeeh Hospital Co. (4017) reported full year 2025 revenue of SAR 3.09B, up 10.7% from SAR 2.79B in 2024. Net profit came in at SAR 248M, down 5.9% year on year. Earnings per share were SAR 1.26. The company generated SAR 454M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.83 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.83.

Key Financial Metrics

Metric	2025	2024
Revenue	SAR 3.09B	SAR 2.79B
Net Profit	SAR 248M	SAR 264M
Net Margin	8.0%	9.4%
ROE	7.8%	8.9%
EPS	SAR 1.26	SAR 1.32
Total Assets	SAR 5.83B	SAR 5.32B
Total Equity	SAR 3.17B	SAR 2.95B
Total Liabilities	SAR 2.25B	SAR 2.00B
Operating Cash Flow	SAR 454M	SAR 436M

Year on Year Comparison

Revenue increased by 10.7% compared to 2024. Net profit decreased by 5.9%. Revenue grew but profit declined — suggesting margin pressure.

View full company profile →

View all years:

2025 2024 2023

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-03-04.